nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—ADORA1—nerve—multiple sclerosis	0.0169	0.0798	CbGeAlD
Gabapentin—BCAT1—retina—multiple sclerosis	0.011	0.052	CbGeAlD
Gabapentin—CACNA1B—medulla oblongata—multiple sclerosis	0.0101	0.0478	CbGeAlD
Gabapentin—CACNA1B—midbrain—multiple sclerosis	0.00925	0.0436	CbGeAlD
Gabapentin—CACNA1B—spinal cord—multiple sclerosis	0.00902	0.0426	CbGeAlD
Gabapentin—BCAT1—medulla oblongata—multiple sclerosis	0.00796	0.0376	CbGeAlD
Gabapentin—CACNA1B—nervous system—multiple sclerosis	0.0076	0.0359	CbGeAlD
Gabapentin—CACNA2D1—brainstem—multiple sclerosis	0.00753	0.0355	CbGeAlD
Gabapentin—CACNA1B—central nervous system—multiple sclerosis	0.00732	0.0345	CbGeAlD
Gabapentin—BCAT1—midbrain—multiple sclerosis	0.00727	0.0343	CbGeAlD
Gabapentin—CACNA1B—cerebellum—multiple sclerosis	0.00715	0.0338	CbGeAlD
Gabapentin—BCAT1—spinal cord—multiple sclerosis	0.0071	0.0335	CbGeAlD
Gabapentin—CACNA2D2—midbrain—multiple sclerosis	0.00667	0.0315	CbGeAlD
Gabapentin—CACNA2D2—spinal cord—multiple sclerosis	0.00651	0.0307	CbGeAlD
Gabapentin—BCAT1—nervous system—multiple sclerosis	0.00598	0.0282	CbGeAlD
Gabapentin—CACNA1B—brain—multiple sclerosis	0.00581	0.0274	CbGeAlD
Gabapentin—BCAT1—central nervous system—multiple sclerosis	0.00576	0.0272	CbGeAlD
Gabapentin—BCAT1—cerebellum—multiple sclerosis	0.00563	0.0266	CbGeAlD
Gabapentin—CACNA2D2—nervous system—multiple sclerosis	0.00548	0.0259	CbGeAlD
Gabapentin—CACNA2D2—central nervous system—multiple sclerosis	0.00528	0.0249	CbGeAlD
Gabapentin—CACNA2D2—cerebellum—multiple sclerosis	0.00516	0.0243	CbGeAlD
Gabapentin—ADORA1—medulla oblongata—multiple sclerosis	0.00506	0.0239	CbGeAlD
Gabapentin—ADORA1—midbrain—multiple sclerosis	0.00463	0.0218	CbGeAlD
Gabapentin—BCAT1—brain—multiple sclerosis	0.00457	0.0216	CbGeAlD
Gabapentin—ADORA1—spinal cord—multiple sclerosis	0.00451	0.0213	CbGeAlD
Gabapentin—CACNA2D2—brain—multiple sclerosis	0.00419	0.0198	CbGeAlD
Gabapentin—CACNA2D1—nervous system—multiple sclerosis	0.00394	0.0186	CbGeAlD
Gabapentin—ADORA1—nervous system—multiple sclerosis	0.0038	0.018	CbGeAlD
Gabapentin—CACNA2D1—central nervous system—multiple sclerosis	0.0038	0.0179	CbGeAlD
Gabapentin—CACNA2D1—cerebellum—multiple sclerosis	0.00371	0.0175	CbGeAlD
Gabapentin—ADORA1—central nervous system—multiple sclerosis	0.00366	0.0173	CbGeAlD
Gabapentin—ADORA1—cerebellum—multiple sclerosis	0.00358	0.0169	CbGeAlD
Gabapentin—CACNA2D1—brain—multiple sclerosis	0.00301	0.0142	CbGeAlD
Gabapentin—ADORA1—brain—multiple sclerosis	0.00291	0.0137	CbGeAlD
Gabapentin—BCAT1—Amino acid and derivative metabolism—SRM—multiple sclerosis	0.00108	0.075	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—KCNA3—multiple sclerosis	0.00079	0.0547	CbGpPWpGaD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—multiple sclerosis	0.000726	0.0503	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—RGS1—multiple sclerosis	0.000672	0.0465	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—KCNA3—multiple sclerosis	0.000523	0.0362	CbGpPWpGaD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—multiple sclerosis	0.000405	0.028	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000289	0.02	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—S1PR1—multiple sclerosis	0.000258	0.0179	CbGpPWpGaD
Gabapentin—Mental disorder—Prednisone—multiple sclerosis	0.000249	0.000322	CcSEcCtD
Gabapentin—Nausea—Azathioprine—multiple sclerosis	0.000249	0.000322	CcSEcCtD
Gabapentin—Tachycardia—Methylprednisolone—multiple sclerosis	0.000249	0.000322	CcSEcCtD
Gabapentin—Skin disorder—Methylprednisolone—multiple sclerosis	0.000248	0.000321	CcSEcCtD
Gabapentin—Malnutrition—Prednisone—multiple sclerosis	0.000248	0.00032	CcSEcCtD
Gabapentin—Erythema—Prednisone—multiple sclerosis	0.000248	0.00032	CcSEcCtD
Gabapentin—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000247	0.00032	CcSEcCtD
Gabapentin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000247	0.000319	CcSEcCtD
Gabapentin—Convulsion—Dexamethasone—multiple sclerosis	0.000247	0.000319	CcSEcCtD
Gabapentin—Convulsion—Betamethasone—multiple sclerosis	0.000247	0.000319	CcSEcCtD
Gabapentin—Hypertension—Betamethasone—multiple sclerosis	0.000246	0.000318	CcSEcCtD
Gabapentin—Hypertension—Dexamethasone—multiple sclerosis	0.000246	0.000318	CcSEcCtD
Gabapentin—Asthenia—Mitoxantrone—multiple sclerosis	0.000243	0.000315	CcSEcCtD
Gabapentin—Myalgia—Dexamethasone—multiple sclerosis	0.000242	0.000313	CcSEcCtD
Gabapentin—Myalgia—Betamethasone—multiple sclerosis	0.000242	0.000313	CcSEcCtD
Gabapentin—Anxiety—Betamethasone—multiple sclerosis	0.000241	0.000312	CcSEcCtD
Gabapentin—Anxiety—Dexamethasone—multiple sclerosis	0.000241	0.000312	CcSEcCtD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—MMP9—multiple sclerosis	0.00024	0.0166	CbGpPWpGaD
Gabapentin—Discomfort—Betamethasone—multiple sclerosis	0.000239	0.000309	CcSEcCtD
Gabapentin—Discomfort—Dexamethasone—multiple sclerosis	0.000239	0.000309	CcSEcCtD
Gabapentin—Hypotension—Methylprednisolone—multiple sclerosis	0.000239	0.000308	CcSEcCtD
Gabapentin—Pain—Prednisolone—multiple sclerosis	0.000238	0.000308	CcSEcCtD
Gabapentin—Haemorrhage—Methotrexate—multiple sclerosis	0.000238	0.000308	CcSEcCtD
Gabapentin—Hepatitis—Methotrexate—multiple sclerosis	0.000238	0.000308	CcSEcCtD
Gabapentin—Pharyngitis—Methotrexate—multiple sclerosis	0.000236	0.000305	CcSEcCtD
Gabapentin—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000235	0.000304	CcSEcCtD
Gabapentin—Vision blurred—Prednisone—multiple sclerosis	0.000234	0.000302	CcSEcCtD
Gabapentin—Urethral disorder—Methotrexate—multiple sclerosis	0.000233	0.000301	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000233	0.000301	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000233	0.000301	CcSEcCtD
Gabapentin—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000232	0.0003	CcSEcCtD
Gabapentin—Oedema—Betamethasone—multiple sclerosis	0.000232	0.0003	CcSEcCtD
Gabapentin—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000232	0.0003	CcSEcCtD
Gabapentin—Oedema—Dexamethasone—multiple sclerosis	0.000232	0.0003	CcSEcCtD
Gabapentin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000232	0.0003	CcSEcCtD
Gabapentin—Insomnia—Triamcinolone—multiple sclerosis	0.000231	0.000299	CcSEcCtD
Gabapentin—Insomnia—Methylprednisolone—multiple sclerosis	0.000231	0.000299	CcSEcCtD
Gabapentin—Infection—Dexamethasone—multiple sclerosis	0.000231	0.000298	CcSEcCtD
Gabapentin—Infection—Betamethasone—multiple sclerosis	0.000231	0.000298	CcSEcCtD
Gabapentin—Ill-defined disorder—Prednisone—multiple sclerosis	0.00023	0.000297	CcSEcCtD
Gabapentin—Paraesthesia—Triamcinolone—multiple sclerosis	0.00023	0.000297	CcSEcCtD
Gabapentin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000229	0.000296	CcSEcCtD
Gabapentin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000229	0.000296	CcSEcCtD
Gabapentin—Visual impairment—Methotrexate—multiple sclerosis	0.000229	0.000296	CcSEcCtD
Gabapentin—Anaemia—Prednisone—multiple sclerosis	0.000229	0.000296	CcSEcCtD
Gabapentin—Shock—Dexamethasone—multiple sclerosis	0.000228	0.000295	CcSEcCtD
Gabapentin—Shock—Betamethasone—multiple sclerosis	0.000228	0.000295	CcSEcCtD
Gabapentin—Dyspnoea—Triamcinolone—multiple sclerosis	0.000228	0.000295	CcSEcCtD
Gabapentin—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000228	0.000294	CcSEcCtD
Gabapentin—Nervous system disorder—Betamethasone—multiple sclerosis	0.000228	0.000294	CcSEcCtD
Gabapentin—Agitation—Prednisone—multiple sclerosis	0.000228	0.000294	CcSEcCtD
Gabapentin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000227	0.000294	CcSEcCtD
Gabapentin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000227	0.000294	CcSEcCtD
Gabapentin—Tachycardia—Dexamethasone—multiple sclerosis	0.000227	0.000293	CcSEcCtD
Gabapentin—Tachycardia—Betamethasone—multiple sclerosis	0.000227	0.000293	CcSEcCtD
Gabapentin—Angioedema—Prednisone—multiple sclerosis	0.000226	0.000293	CcSEcCtD
Gabapentin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000225	0.000291	CcSEcCtD
Gabapentin—Erythema multiforme—Methotrexate—multiple sclerosis	0.000225	0.000291	CcSEcCtD
Gabapentin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000225	0.000291	CcSEcCtD
Gabapentin—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000225	0.00029	CcSEcCtD
Gabapentin—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000225	0.00029	CcSEcCtD
Gabapentin—Malaise—Prednisone—multiple sclerosis	0.000223	0.000289	CcSEcCtD
Gabapentin—Vertigo—Prednisone—multiple sclerosis	0.000223	0.000288	CcSEcCtD
Gabapentin—Eye disorder—Methotrexate—multiple sclerosis	0.000222	0.000287	CcSEcCtD
Gabapentin—Syncope—Prednisone—multiple sclerosis	0.000222	0.000287	CcSEcCtD
Gabapentin—Tinnitus—Methotrexate—multiple sclerosis	0.000222	0.000287	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—BCHE—multiple sclerosis	0.000221	0.0153	CbGpPWpGaD
Gabapentin—Anorexia—Dexamethasone—multiple sclerosis	0.000221	0.000286	CcSEcCtD
Gabapentin—Anorexia—Betamethasone—multiple sclerosis	0.000221	0.000286	CcSEcCtD
Gabapentin—Urticaria—Prednisolone—multiple sclerosis	0.000221	0.000286	CcSEcCtD
Gabapentin—Cardiac disorder—Methotrexate—multiple sclerosis	0.000221	0.000285	CcSEcCtD
Gabapentin—Fatigue—Triamcinolone—multiple sclerosis	0.000221	0.000285	CcSEcCtD
Gabapentin—Fatigue—Methylprednisolone—multiple sclerosis	0.00022	0.000285	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—RGS1—multiple sclerosis	0.000219	0.0152	CbGpPWpGaD
Gabapentin—Pain—Triamcinolone—multiple sclerosis	0.000219	0.000283	CcSEcCtD
Gabapentin—Loss of consciousness—Prednisone—multiple sclerosis	0.000218	0.000282	CcSEcCtD
Gabapentin—Hypotension—Dexamethasone—multiple sclerosis	0.000217	0.00028	CcSEcCtD
Gabapentin—Hypotension—Betamethasone—multiple sclerosis	0.000217	0.00028	CcSEcCtD
Gabapentin—Vomiting—Mitoxantrone—multiple sclerosis	0.000216	0.000279	CcSEcCtD
Gabapentin—Immune system disorder—Methotrexate—multiple sclerosis	0.000215	0.000278	CcSEcCtD
Gabapentin—Convulsion—Prednisone—multiple sclerosis	0.000215	0.000278	CcSEcCtD
Gabapentin—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000214	0.000277	CcSEcCtD
Gabapentin—Hypertension—Prednisone—multiple sclerosis	0.000214	0.000277	CcSEcCtD
Gabapentin—Rash—Mitoxantrone—multiple sclerosis	0.000214	0.000276	CcSEcCtD
Gabapentin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000214	0.000276	CcSEcCtD
Gabapentin—Chills—Methotrexate—multiple sclerosis	0.000213	0.000276	CcSEcCtD
Gabapentin—Headache—Mitoxantrone—multiple sclerosis	0.000213	0.000275	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000212	0.000273	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000212	0.000273	CcSEcCtD
Gabapentin—Arthralgia—Prednisone—multiple sclerosis	0.000211	0.000273	CcSEcCtD
Gabapentin—Myalgia—Prednisone—multiple sclerosis	0.000211	0.000273	CcSEcCtD
Gabapentin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000211	0.000273	CcSEcCtD
Gabapentin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00021	0.000272	CcSEcCtD
Gabapentin—Anxiety—Prednisone—multiple sclerosis	0.00021	0.000272	CcSEcCtD
Gabapentin—Alopecia—Methotrexate—multiple sclerosis	0.00021	0.000272	CcSEcCtD
Gabapentin—Insomnia—Dexamethasone—multiple sclerosis	0.00021	0.000271	CcSEcCtD
Gabapentin—Insomnia—Betamethasone—multiple sclerosis	0.00021	0.000271	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00021	0.000271	CcSEcCtD
Gabapentin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000209	0.00027	CcSEcCtD
Gabapentin—Paraesthesia—Betamethasone—multiple sclerosis	0.000209	0.00027	CcSEcCtD
Gabapentin—Paraesthesia—Dexamethasone—multiple sclerosis	0.000209	0.00027	CcSEcCtD
Gabapentin—Discomfort—Prednisone—multiple sclerosis	0.000208	0.000269	CcSEcCtD
Gabapentin—Mental disorder—Methotrexate—multiple sclerosis	0.000208	0.000269	CcSEcCtD
Gabapentin—Erythema—Methotrexate—multiple sclerosis	0.000207	0.000268	CcSEcCtD
Gabapentin—Malnutrition—Methotrexate—multiple sclerosis	0.000207	0.000268	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.000205	0.0142	CbGpPWpGaD
Gabapentin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000205	0.000265	CcSEcCtD
Gabapentin—Dyspepsia—Betamethasone—multiple sclerosis	0.000204	0.000264	CcSEcCtD
Gabapentin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000204	0.000264	CcSEcCtD
Gabapentin—Urticaria—Triamcinolone—multiple sclerosis	0.000203	0.000263	CcSEcCtD
Gabapentin—Urticaria—Methylprednisolone—multiple sclerosis	0.000203	0.000262	CcSEcCtD
Gabapentin—Dysgeusia—Methotrexate—multiple sclerosis	0.000203	0.000262	CcSEcCtD
Gabapentin—Body temperature increased—Triamcinolone—multiple sclerosis	0.000202	0.000262	CcSEcCtD
Gabapentin—Anaphylactic shock—Prednisone—multiple sclerosis	0.000202	0.000261	CcSEcCtD
Gabapentin—Oedema—Prednisone—multiple sclerosis	0.000202	0.000261	CcSEcCtD
Gabapentin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000202	0.000261	CcSEcCtD
Gabapentin—Decreased appetite—Dexamethasone—multiple sclerosis	0.000202	0.000261	CcSEcCtD
Gabapentin—Decreased appetite—Betamethasone—multiple sclerosis	0.000202	0.000261	CcSEcCtD
Gabapentin—Nausea—Mitoxantrone—multiple sclerosis	0.000202	0.00026	CcSEcCtD
Gabapentin—Infection—Prednisone—multiple sclerosis	0.000201	0.00026	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000201	0.000259	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000201	0.000259	CcSEcCtD
Gabapentin—Back pain—Methotrexate—multiple sclerosis	0.0002	0.000259	CcSEcCtD
Gabapentin—Fatigue—Betamethasone—multiple sclerosis	0.0002	0.000259	CcSEcCtD
Gabapentin—Fatigue—Dexamethasone—multiple sclerosis	0.0002	0.000259	CcSEcCtD
Gabapentin—Shock—Prednisone—multiple sclerosis	0.000199	0.000257	CcSEcCtD
Gabapentin—BCAT1—Metabolism—SRM—multiple sclerosis	0.000199	0.0138	CbGpPWpGaD
Gabapentin—Pain—Dexamethasone—multiple sclerosis	0.000199	0.000257	CcSEcCtD
Gabapentin—Pain—Betamethasone—multiple sclerosis	0.000199	0.000257	CcSEcCtD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—MYC—multiple sclerosis	0.000198	0.0137	CbGpPWpGaD
Gabapentin—Nervous system disorder—Prednisone—multiple sclerosis	0.000198	0.000256	CcSEcCtD
Gabapentin—Tachycardia—Prednisone—multiple sclerosis	0.000197	0.000255	CcSEcCtD
Gabapentin—Skin disorder—Prednisone—multiple sclerosis	0.000196	0.000254	CcSEcCtD
Gabapentin—Hyperhidrosis—Prednisone—multiple sclerosis	0.000196	0.000253	CcSEcCtD
Gabapentin—Vision blurred—Methotrexate—multiple sclerosis	0.000195	0.000252	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.000193	0.0134	CbGpPWpGaD
Gabapentin—Anorexia—Prednisone—multiple sclerosis	0.000193	0.000249	CcSEcCtD
Gabapentin—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000192	0.000248	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000191	0.0133	CbGpPWpGaD
Gabapentin—Anaemia—Methotrexate—multiple sclerosis	0.000191	0.000247	CcSEcCtD
Gabapentin—Feeling abnormal—Betamethasone—multiple sclerosis	0.000191	0.000247	CcSEcCtD
Gabapentin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000191	0.000247	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—CCR1—multiple sclerosis	0.00019	0.0132	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CXCL13—multiple sclerosis	0.00019	0.0132	CbGpPWpGaD
Gabapentin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00019	0.000245	CcSEcCtD
Gabapentin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00019	0.000245	CcSEcCtD
Gabapentin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000189	0.000244	CcSEcCtD
Gabapentin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000188	0.000243	CcSEcCtD
Gabapentin—Malaise—Methotrexate—multiple sclerosis	0.000187	0.000241	CcSEcCtD
Gabapentin—Vertigo—Methotrexate—multiple sclerosis	0.000186	0.000241	CcSEcCtD
Gabapentin—Leukopenia—Methotrexate—multiple sclerosis	0.000185	0.00024	CcSEcCtD
Gabapentin—Urticaria—Dexamethasone—multiple sclerosis	0.000184	0.000238	CcSEcCtD
Gabapentin—Urticaria—Betamethasone—multiple sclerosis	0.000184	0.000238	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000184	0.000238	CcSEcCtD
Gabapentin—Dizziness—Prednisolone—multiple sclerosis	0.000184	0.000238	CcSEcCtD
Gabapentin—Asthenia—Triamcinolone—multiple sclerosis	0.000184	0.000237	CcSEcCtD
Gabapentin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000184	0.000237	CcSEcCtD
Gabapentin—Body temperature increased—Dexamethasone—multiple sclerosis	0.000184	0.000237	CcSEcCtD
Gabapentin—Body temperature increased—Betamethasone—multiple sclerosis	0.000184	0.000237	CcSEcCtD
Gabapentin—Abdominal pain—Betamethasone—multiple sclerosis	0.000184	0.000237	CcSEcCtD
Gabapentin—Asthenia—Methylprednisolone—multiple sclerosis	0.000183	0.000237	CcSEcCtD
Gabapentin—Insomnia—Prednisone—multiple sclerosis	0.000183	0.000236	CcSEcCtD
Gabapentin—Paraesthesia—Prednisone—multiple sclerosis	0.000182	0.000235	CcSEcCtD
Gabapentin—Pruritus—Triamcinolone—multiple sclerosis	0.000181	0.000234	CcSEcCtD
Gabapentin—Cough—Methotrexate—multiple sclerosis	0.000181	0.000234	CcSEcCtD
Gabapentin—Pruritus—Methylprednisolone—multiple sclerosis	0.000181	0.000234	CcSEcCtD
Gabapentin—Convulsion—Methotrexate—multiple sclerosis	0.000179	0.000232	CcSEcCtD
Gabapentin—Dyspepsia—Prednisone—multiple sclerosis	0.000178	0.00023	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.000176	0.0122	CbGpPWpGaD
Gabapentin—Chest pain—Methotrexate—multiple sclerosis	0.000176	0.000228	CcSEcCtD
Gabapentin—Arthralgia—Methotrexate—multiple sclerosis	0.000176	0.000228	CcSEcCtD
Gabapentin—Myalgia—Methotrexate—multiple sclerosis	0.000176	0.000228	CcSEcCtD
Gabapentin—Decreased appetite—Prednisone—multiple sclerosis	0.000176	0.000227	CcSEcCtD
Gabapentin—Rash—Prednisolone—multiple sclerosis	0.000175	0.000227	CcSEcCtD
Gabapentin—Dermatitis—Prednisolone—multiple sclerosis	0.000175	0.000227	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000175	0.000226	CcSEcCtD
Gabapentin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000175	0.000226	CcSEcCtD
Gabapentin—Fatigue—Prednisone—multiple sclerosis	0.000174	0.000225	CcSEcCtD
Gabapentin—Headache—Prednisolone—multiple sclerosis	0.000174	0.000225	CcSEcCtD
Gabapentin—Discomfort—Methotrexate—multiple sclerosis	0.000174	0.000225	CcSEcCtD
Gabapentin—Constipation—Prednisone—multiple sclerosis	0.000173	0.000224	CcSEcCtD
Gabapentin—Confusional state—Methotrexate—multiple sclerosis	0.00017	0.00022	CcSEcCtD
Gabapentin—Dizziness—Triamcinolone—multiple sclerosis	0.000169	0.000219	CcSEcCtD
Gabapentin—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000169	0.000218	CcSEcCtD
Gabapentin—Dizziness—Methylprednisolone—multiple sclerosis	0.000169	0.000218	CcSEcCtD
Gabapentin—Infection—Methotrexate—multiple sclerosis	0.000168	0.000217	CcSEcCtD
Gabapentin—Feeling abnormal—Prednisone—multiple sclerosis	0.000167	0.000215	CcSEcCtD
Gabapentin—Asthenia—Dexamethasone—multiple sclerosis	0.000167	0.000215	CcSEcCtD
Gabapentin—Asthenia—Betamethasone—multiple sclerosis	0.000167	0.000215	CcSEcCtD
Gabapentin—Nervous system disorder—Methotrexate—multiple sclerosis	0.000166	0.000214	CcSEcCtD
Gabapentin—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000165	0.000214	CcSEcCtD
Gabapentin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000165	0.000214	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.000165	0.0114	CbGpPWpGaD
Gabapentin—Nausea—Prednisolone—multiple sclerosis	0.000165	0.000214	CcSEcCtD
Gabapentin—Pruritus—Betamethasone—multiple sclerosis	0.000164	0.000212	CcSEcCtD
Gabapentin—Pruritus—Dexamethasone—multiple sclerosis	0.000164	0.000212	CcSEcCtD
Gabapentin—Skin disorder—Methotrexate—multiple sclerosis	0.000164	0.000212	CcSEcCtD
Gabapentin—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000163	0.000211	CcSEcCtD
Gabapentin—Vomiting—Triamcinolone—multiple sclerosis	0.000163	0.00021	CcSEcCtD
Gabapentin—Vomiting—Methylprednisolone—multiple sclerosis	0.000162	0.00021	CcSEcCtD
Gabapentin—Rash—Triamcinolone—multiple sclerosis	0.000161	0.000209	CcSEcCtD
Gabapentin—Dermatitis—Triamcinolone—multiple sclerosis	0.000161	0.000208	CcSEcCtD
Gabapentin—Anorexia—Methotrexate—multiple sclerosis	0.000161	0.000208	CcSEcCtD
Gabapentin—Rash—Methylprednisolone—multiple sclerosis	0.000161	0.000208	CcSEcCtD
Gabapentin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000161	0.000208	CcSEcCtD
Gabapentin—Urticaria—Prednisone—multiple sclerosis	0.000161	0.000208	CcSEcCtD
Gabapentin—Headache—Triamcinolone—multiple sclerosis	0.00016	0.000207	CcSEcCtD
Gabapentin—Headache—Methylprednisolone—multiple sclerosis	0.00016	0.000207	CcSEcCtD
Gabapentin—Body temperature increased—Prednisone—multiple sclerosis	0.00016	0.000207	CcSEcCtD
Gabapentin—Abdominal pain—Prednisone—multiple sclerosis	0.00016	0.000207	CcSEcCtD
Gabapentin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000159	0.000205	CcSEcCtD
Gabapentin—Diarrhoea—Betamethasone—multiple sclerosis	0.000159	0.000205	CcSEcCtD
Gabapentin—Hypotension—Methotrexate—multiple sclerosis	0.000158	0.000204	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—S1PR1—multiple sclerosis	0.000156	0.0108	CbGpPWpGaD
Gabapentin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000154	0.000199	CcSEcCtD
Gabapentin—Dizziness—Dexamethasone—multiple sclerosis	0.000154	0.000198	CcSEcCtD
Gabapentin—Dizziness—Betamethasone—multiple sclerosis	0.000154	0.000198	CcSEcCtD
Gabapentin—Insomnia—Methotrexate—multiple sclerosis	0.000153	0.000198	CcSEcCtD
Gabapentin—Nausea—Triamcinolone—multiple sclerosis	0.000152	0.000197	CcSEcCtD
Gabapentin—Paraesthesia—Methotrexate—multiple sclerosis	0.000152	0.000196	CcSEcCtD
Gabapentin—Nausea—Methylprednisolone—multiple sclerosis	0.000152	0.000196	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.000151	0.0105	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.000151	0.0105	CbGpPWpGaD
Gabapentin—Dyspnoea—Methotrexate—multiple sclerosis	0.000151	0.000195	CcSEcCtD
Gabapentin—Somnolence—Methotrexate—multiple sclerosis	0.00015	0.000194	CcSEcCtD
Gabapentin—Hypersensitivity—Prednisone—multiple sclerosis	0.000149	0.000193	CcSEcCtD
Gabapentin—Dyspepsia—Methotrexate—multiple sclerosis	0.000149	0.000192	CcSEcCtD
Gabapentin—Vomiting—Betamethasone—multiple sclerosis	0.000148	0.000191	CcSEcCtD
Gabapentin—Vomiting—Dexamethasone—multiple sclerosis	0.000148	0.000191	CcSEcCtD
Gabapentin—Decreased appetite—Methotrexate—multiple sclerosis	0.000147	0.00019	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—BCHE—multiple sclerosis	0.000147	0.0102	CbGpPWpGaD
Gabapentin—Rash—Betamethasone—multiple sclerosis	0.000146	0.000189	CcSEcCtD
Gabapentin—Rash—Dexamethasone—multiple sclerosis	0.000146	0.000189	CcSEcCtD
Gabapentin—Dermatitis—Dexamethasone—multiple sclerosis	0.000146	0.000189	CcSEcCtD
Gabapentin—Dermatitis—Betamethasone—multiple sclerosis	0.000146	0.000189	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000146	0.000189	CcSEcCtD
Gabapentin—Fatigue—Methotrexate—multiple sclerosis	0.000146	0.000188	CcSEcCtD
Gabapentin—Headache—Dexamethasone—multiple sclerosis	0.000145	0.000188	CcSEcCtD
Gabapentin—Headache—Betamethasone—multiple sclerosis	0.000145	0.000188	CcSEcCtD
Gabapentin—Asthenia—Prednisone—multiple sclerosis	0.000145	0.000188	CcSEcCtD
Gabapentin—Pain—Methotrexate—multiple sclerosis	0.000145	0.000187	CcSEcCtD
Gabapentin—Pruritus—Prednisone—multiple sclerosis	0.000143	0.000185	CcSEcCtD
Gabapentin—BCAT1—Metabolism—CYP24A1—multiple sclerosis	0.00014	0.0097	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP27B1—multiple sclerosis	0.00014	0.0097	CbGpPWpGaD
Gabapentin—Feeling abnormal—Methotrexate—multiple sclerosis	0.000139	0.00018	CcSEcCtD
Gabapentin—Diarrhoea—Prednisone—multiple sclerosis	0.000138	0.000179	CcSEcCtD
Gabapentin—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000138	0.000179	CcSEcCtD
Gabapentin—Nausea—Betamethasone—multiple sclerosis	0.000138	0.000178	CcSEcCtD
Gabapentin—Nausea—Dexamethasone—multiple sclerosis	0.000138	0.000178	CcSEcCtD
Gabapentin—Urticaria—Methotrexate—multiple sclerosis	0.000134	0.000174	CcSEcCtD
Gabapentin—Dizziness—Prednisone—multiple sclerosis	0.000134	0.000173	CcSEcCtD
Gabapentin—Body temperature increased—Methotrexate—multiple sclerosis	0.000134	0.000173	CcSEcCtD
Gabapentin—Abdominal pain—Methotrexate—multiple sclerosis	0.000134	0.000173	CcSEcCtD
Gabapentin—Vomiting—Prednisone—multiple sclerosis	0.000129	0.000166	CcSEcCtD
Gabapentin—BCAT1—Metabolism—GPC5—multiple sclerosis	0.000128	0.00887	CbGpPWpGaD
Gabapentin—Rash—Prednisone—multiple sclerosis	0.000128	0.000165	CcSEcCtD
Gabapentin—Dermatitis—Prednisone—multiple sclerosis	0.000127	0.000165	CcSEcCtD
Gabapentin—Headache—Prednisone—multiple sclerosis	0.000127	0.000164	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—CXCR3—multiple sclerosis	0.000126	0.00872	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—GPR65—multiple sclerosis	0.000126	0.00872	CbGpPWpGaD
Gabapentin—Hypersensitivity—Methotrexate—multiple sclerosis	0.000125	0.000161	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—CCR2—multiple sclerosis	0.000123	0.00849	CbGpPWpGaD
Gabapentin—Asthenia—Methotrexate—multiple sclerosis	0.000121	0.000157	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.000121	0.00838	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SRM—multiple sclerosis	0.00012	0.00834	CbGpPWpGaD
Gabapentin—Nausea—Prednisone—multiple sclerosis	0.00012	0.000155	CcSEcCtD
Gabapentin—Pruritus—Methotrexate—multiple sclerosis	0.00012	0.000155	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000117	0.0081	CbGpPWpGaD
Gabapentin—Diarrhoea—Methotrexate—multiple sclerosis	0.000116	0.000149	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—CCR1—multiple sclerosis	0.000115	0.00797	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CXCL13—multiple sclerosis	0.000115	0.00797	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000114	0.00788	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CNR1—multiple sclerosis	0.000113	0.00783	CbGpPWpGaD
Gabapentin—Dizziness—Methotrexate—multiple sclerosis	0.000112	0.000144	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000108	0.00746	CbGpPWpGaD
Gabapentin—Vomiting—Methotrexate—multiple sclerosis	0.000107	0.000139	CcSEcCtD
Gabapentin—Rash—Methotrexate—multiple sclerosis	0.000107	0.000138	CcSEcCtD
Gabapentin—Dermatitis—Methotrexate—multiple sclerosis	0.000106	0.000138	CcSEcCtD
Gabapentin—BCAT1—Metabolism—RRM1—multiple sclerosis	0.000106	0.00735	CbGpPWpGaD
Gabapentin—Headache—Methotrexate—multiple sclerosis	0.000106	0.000137	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.000105	0.00727	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000104	0.00718	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CXCL10—multiple sclerosis	0.000102	0.00705	CbGpPWpGaD
Gabapentin—Nausea—Methotrexate—multiple sclerosis	0.0001	0.00013	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.0001	0.00694	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	9.74e-05	0.00675	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	8.99e-05	0.00623	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—FAS—multiple sclerosis	8.87e-05	0.00614	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—S1PR1—multiple sclerosis	8.83e-05	0.00611	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CCL5—multiple sclerosis	8.77e-05	0.00607	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP27B1—multiple sclerosis	8.49e-05	0.00588	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP24A1—multiple sclerosis	8.49e-05	0.00588	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	8.45e-05	0.00585	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCL3—multiple sclerosis	8.21e-05	0.00568	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	8.1e-05	0.00561	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—S1PR1—multiple sclerosis	8.02e-05	0.00555	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—PTGER4—multiple sclerosis	7.9e-05	0.00547	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CCR5—multiple sclerosis	7.9e-05	0.00547	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GPC5—multiple sclerosis	7.76e-05	0.00538	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CXCR3—multiple sclerosis	7.63e-05	0.00528	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—RGS1—multiple sclerosis	7.51e-05	0.0052	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCR2—multiple sclerosis	7.42e-05	0.00514	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	7.33e-05	0.00508	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GPR65—multiple sclerosis	7.12e-05	0.00493	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	6.97e-05	0.00483	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CNR1—multiple sclerosis	6.85e-05	0.00474	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—RGS1—multiple sclerosis	6.82e-05	0.00472	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CCR1—multiple sclerosis	6.51e-05	0.00451	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCL13—multiple sclerosis	6.51e-05	0.00451	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—MAPK1—multiple sclerosis	6.47e-05	0.00448	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GPR65—multiple sclerosis	6.46e-05	0.00447	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—RRM1—multiple sclerosis	6.43e-05	0.00445	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	6.28e-05	0.00435	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LINGO1—multiple sclerosis	6.25e-05	0.00433	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—POMC—multiple sclerosis	6.17e-05	0.00427	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CXCL10—multiple sclerosis	6.17e-05	0.00427	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—BCHE—multiple sclerosis	6.1e-05	0.00422	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCR1—multiple sclerosis	5.91e-05	0.00409	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCL13—multiple sclerosis	5.91e-05	0.00409	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.6e-05	0.00388	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TAGAP—multiple sclerosis	5.42e-05	0.00375	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCL5—multiple sclerosis	5.31e-05	0.00368	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	4.91e-05	0.0034	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	4.8e-05	0.00333	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCR5—multiple sclerosis	4.78e-05	0.00331	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—S1PR1—multiple sclerosis	4.74e-05	0.00328	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GPC5—multiple sclerosis	4.61e-05	0.00319	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PTGER4—multiple sclerosis	4.46e-05	0.00309	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCR3—multiple sclerosis	4.31e-05	0.00299	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—MAPK1—multiple sclerosis	4.29e-05	0.00297	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCL3—multiple sclerosis	4.21e-05	0.00292	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CCR2—multiple sclerosis	4.19e-05	0.0029	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PTGER4—multiple sclerosis	4.05e-05	0.00281	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RGS1—multiple sclerosis	4.03e-05	0.00279	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCR3—multiple sclerosis	3.91e-05	0.00271	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CNR1—multiple sclerosis	3.87e-05	0.00268	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GPR65—multiple sclerosis	3.82e-05	0.00264	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCR2—multiple sclerosis	3.81e-05	0.00264	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—POMC—multiple sclerosis	3.74e-05	0.00259	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—BCHE—multiple sclerosis	3.69e-05	0.00256	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOE—multiple sclerosis	3.67e-05	0.00254	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCL2—multiple sclerosis	3.66e-05	0.00253	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CNR1—multiple sclerosis	3.51e-05	0.00243	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCR1—multiple sclerosis	3.49e-05	0.00242	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL13—multiple sclerosis	3.49e-05	0.00242	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCL10—multiple sclerosis	3.48e-05	0.00241	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCL10—multiple sclerosis	3.16e-05	0.00219	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—POMC—multiple sclerosis	3.15e-05	0.00218	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—IL6—multiple sclerosis	3.04e-05	0.0021	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CCL5—multiple sclerosis	3e-05	0.00208	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ALB—multiple sclerosis	2.87e-05	0.00199	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCL5—multiple sclerosis	2.72e-05	0.00189	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CCR5—multiple sclerosis	2.7e-05	0.00187	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—IL2RA—multiple sclerosis	2.66e-05	0.00184	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL3—multiple sclerosis	2.49e-05	0.00172	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCR5—multiple sclerosis	2.45e-05	0.0017	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL2RA—multiple sclerosis	2.42e-05	0.00167	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTGER4—multiple sclerosis	2.39e-05	0.00166	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PGR—multiple sclerosis	2.36e-05	0.00163	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCR3—multiple sclerosis	2.31e-05	0.0016	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CD28—multiple sclerosis	2.29e-05	0.00159	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCR2—multiple sclerosis	2.25e-05	0.00156	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOE—multiple sclerosis	2.22e-05	0.00154	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—POMC—multiple sclerosis	2.11e-05	0.00146	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CNR1—multiple sclerosis	2.08e-05	0.00144	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—POMC—multiple sclerosis	1.92e-05	0.00133	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—POMC—multiple sclerosis	1.91e-05	0.00132	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCL2—multiple sclerosis	1.88e-05	0.0013	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL10—multiple sclerosis	1.87e-05	0.00129	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALB—multiple sclerosis	1.74e-05	0.00121	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—TYK2—multiple sclerosis	1.7e-05	0.00118	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CD86—multiple sclerosis	1.63e-05	0.00113	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL5—multiple sclerosis	1.61e-05	0.00111	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—IL2—multiple sclerosis	1.56e-05	0.00108	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SPP1—multiple sclerosis	1.49e-05	0.00103	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCR5—multiple sclerosis	1.45e-05	0.001	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL2RA—multiple sclerosis	1.43e-05	0.000989	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL2—multiple sclerosis	1.42e-05	0.000982	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOE—multiple sclerosis	1.32e-05	0.000913	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CD80—multiple sclerosis	1.19e-05	0.000826	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—POMC—multiple sclerosis	1.13e-05	0.000785	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL2—multiple sclerosis	1.11e-05	0.000768	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MAPK1—multiple sclerosis	1.08e-05	0.000751	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TYK2—multiple sclerosis	1.01e-05	0.000697	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL2—multiple sclerosis	8.38e-06	0.00058	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6—multiple sclerosis	8.33e-06	0.000577	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MMP9—multiple sclerosis	7.93e-06	0.000549	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STAT3—multiple sclerosis	7.05e-06	0.000488	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MYC—multiple sclerosis	6.55e-06	0.000454	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TGFB1—multiple sclerosis	6.53e-06	0.000452	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAPK1—multiple sclerosis	6.41e-06	0.000444	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6—multiple sclerosis	4.92e-06	0.000341	CbGpPWpGaD
